2012 Mar 7
Who May Qualify for a GLP-1 Lawsuit You may qualify for a GLP-1 injury claim if you meet the following criteria: Medication: Use of a brand-name GLP-1 drug Ozempic, Wegovy, Mounjaro, Trulicity, or Rybelsus Duration: Used the medication for at least 23 months Purpose: Prescribed for weight loss or diabetes Injury: Gastroparesis a condition characterized by partial or complete paralysis of the stomach, leading to delayed gastric emptying Severe intestinal obstruction (ileus) a disruption of normal bowel function causing significant blockage of the intestines Gallbladder disease resulting in cholecystectomy (surgical removal of the gallbladder) prior to 2022 Treatment: Emergency room or hospital visit required Common GLP-1 Side Effects and Injuries While many patients tolerate GLP-1 receptor agonists well, others experience debilitating side effects such as chronic nausea, vomiting, abdominal pain, dehydration, and severe gastrointestinal distress

Giving states latitude in how they cover the drugs, analysts say, could help limit upfront costs and potentially promise states savings on medical care for heart disease, type 2 diabetes, and other weight-related conditions
Many of the same storage principles apply to other peptides in your research library, from tirzepatide refrigeration requirements to compounded semaglutide storage and fridge shelf life for compounded formulations
STEP 1: Complete an online medical intake form detailing your health and weight loss goals
And does the delivery method change the equation